The health and lifestyle resource’s latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.
The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don’t work correctly.
Business briefs: Biosimilars, Johnson & Johnson, Consumer Reports
August 29, 2013
5:57 pm
FDA is concerned state biosimilar legislation could make consumers uneasy about the category, J&J hands $75 million milestone payment for ibrutinib, Consumer Reports gets into drug apps
A Parkinson’s app for patients that took its cue from HCPs